Suggestions on the management of cardiovascular disease risk factors in patients with human immunodeficiency virus infection

中华传染病杂志 Pub Date : 2020-02-15 DOI:10.3760/CMA.J.ISSN.1000-6680.2020.02.003

W. Lyu, Xue Lin

引用次数: 0

Abstract

抗反转录病毒治疗(antiretroviral therapy，ART)的出现与普及大大延长了人类免疫缺陷病毒(human immunodeficiency virus，HIV)感染者的生存期，但同时该人群的心血管疾病患病率也逐步升高。现借鉴国内外指南及学术报道，结合我国艾滋病和心血管病领域专家的临床经验，对中国HIV感染者的心血管疾病预防，特别是血脂异常和高血压这两个危险因素的管理提出建议，为临床医护人员提供参考。HIV感染者的心血管疾病危险因素会随着地域、感染原因的不同而有所差异，本建议基于现有临床证据和国内外文献提出，医护人员在临床实践时需结合当地HIV感染的具体情况确定患者的治疗策略。

查看原文本刊更多论文

对人类免疫缺陷病毒感染者心血管疾病危险因素管理的建议

The emergence and popularization of antiretroviral therapy (ART) have greatly extended the survival period of people infected with human immunodeficiency virus (HIV), but at the same time, the incidence of cardiovascular diseases in this population is gradually increasing. Based on the domestic and foreign guidelines and academic reports, and combined with the clinical experience of experts in the field of AIDS and cardiovascular disease in China, this paper puts forward suggestions on the prevention of cardiovascular disease of HIV infected people in China, especially the management of the two risk factors of dyslipidemia and hypertension, so as to provide reference for clinical doctors and nurses. The risk factors for cardiovascular disease in HIV infected individuals may vary depending on region and cause of infection. Based on existing clinical evidence and domestic and foreign literature, this recommendation suggests that medical staff should determine treatment strategies for patients in clinical practice, taking into account the specific situation of local HIV infection.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

中华传染病杂志

自引率

0.00%

发文量

5280

期刊介绍：